10.01.03
Next Pharmaceuticals, Inc., Irvine, CA, has been issued U.S. patent No. 6,582,735 on magnolia, a key component in the company’s all natural, anti-stress ingredient Relora®. The patented methodology relates to the use of Relora® for weight gain associated with stress and a stress-related condition known as “metabolic syndrome.”